CheKine™ Micro LPL Activity Assay Kit: Replacing Radioactive Substrates with a Non-Radioactive, 3-Hour Solution
LPL: The Metabolic Traffic Cop of Lipid Homeostasis
Lipoprotein lipase (LPL) acts as the metabolic traffic cop, directing triglyceride-derived fatty acids into adipose tissue for storage or into muscle and heart for energy production[reference:59]. Dysregulated LPL activity lies at the heart of hypertriglyceridemia, familial chylomicronemia, obesity-driven insulin resistance, and atherosclerotic cardiovascular disease[reference:60].
Yet, conventional LPL assays are notoriously challenging: they often require radioactive substrates like ³H-triolein, tedious ultracentrifugation to isolate lipoproteins, or complex post-reaction extraction steps that limit throughput and reproducibility[reference:61].
Why Abbkine KTB2251 Outperforms the Competition
| Feature | Abbkine KTB2251 | Traditional LPL Assays |
|---|---|---|
| Detection Principle | Non-radioactive colorimetric microplate assay[reference:62] | Radioactive substrates (³H-triolein)[reference:63] |
| Assay Time | Under 3 hours[reference:64] | Hours to days |
| Safety | Non-radioactive | Hazardous isotope handling |
| Specificity | Proprietary LPL-selective chromogenic substrate[reference:65] | Cross-reacts with pancreatic lipase, hepatic lipase[reference:66] |
| Throughput | 96-well microplate | Low; requires ultracentrifugation[reference:67] |
| Sample Types | Plasma, tissue homogenates, cell lysates[reference:68] | Limited |
| Price | $109 for 48 tests/24 standards[reference:69] | Premium alternatives cost significantly more |
The Coupled Enzyme System Advantage
The kit uses a synthetic triglyceride substrate and a coupled enzyme system that generates a measurable color change[reference:70]. Instead of radioactive ³H-triolein emulsions that require heparin-release steps to detach endothelial-bound LPL and complex post-reaction extraction, KTB2251 provides a simple, non-radioactive colorimetric readout[reference:71].
LPL hydrolyzes triglycerides (TGs) from circulating chylomicrons and very-low-density lipoproteins (VLDL), releasing free fatty acids (FFAs) and glycerol for tissue uptake[reference:72]. The color intensity is proportional to LPL activity.
Applications Across Research Fields
- Familial Hyperlipidemia — studying LPL mutations in type I hyperlipidemia[reference:73]
- Atherosclerosis & Cardiovascular Disease — LPL activity predicts cardiovascular risk[reference:74]
- Obesity & Type 2 Diabetes — adipose-tissue LPL is often upregulated in obesity, promoting fat storage and ectopic lipid deposition[reference:75]
- Drug Discovery — screening LPL-modulating drugs[reference:76]
Practical Tips for Success
- Serum/plasma: Collect in EDTA or heparin tubes; centrifuge at 3,000×g for 15 min at 4°C; dilute 1:5 with Sample Dilution Buffer + 10 U/mL heparin[reference:77]
- Adipose tissue: Homogenize 50 mg fresh tissue in 1 mL ice-cold Lysis Buffer with 1 mM PMSF and 0.1% Triton X-100[reference:78]
- Cell cultures: Seed to 80% confluency, wash with ice-cold PBS, lyse in 200 µL Lysis Buffer per well[reference:79]
- Normalize to protein content: Quantify total protein via BCA assay[reference:80]
- Temperature: Bring all components to 25°C for 20 minutes before use[reference:81]
The Bottom Line
For researchers investigating LPL in lipid metabolism, cardiovascular disease, or diabetes, KTB2251 delivers the specificity, sensitivity, and safety that modern lipoprotein research demands—replacing hazardous radioactive substrates with a simple, non-radioactive colorimetric assay[reference:82].
👉 Quantify LPL activity with confidence. View Product
